<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title>PLoS ONE</journal-title><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">08-PONE-RA-06730</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0003688</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Immunology</subject><subject>Immunology/Innate Immunity</subject><subject>Immunology/Leukocyte Development</subject></subj-group></article-categories><title-group><article-title>Identification of CD4<sup>&#x02212;</sup>CD8<sup>&#x02212;</sup> Double-Negative Natural Killer T Cell Precursors in the Thymus</article-title><alt-title alt-title-type="running-head">Thymic NKT Cell Precursor</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Dashtsoodol</surname><given-names>Nyambayar</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Watarai</surname><given-names>Hiroshi</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Sakata</surname><given-names>Sakura</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Taniguchi</surname><given-names>Masaru</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Laboratory for Immune Regulation, RIKEN Research Center for Allergy and Immunology, Tsurumi-ku, Yokohama, Kanagawa, Japan</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Sandberg</surname><given-names>Johan K.</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">Karolinska Institutet, Sweden</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>taniguti@rcai.riken.jp</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: ND HW MT. Performed the experiments: ND SS. Analyzed the data: ND MT. Wrote the paper: ND MT.</p></fn></author-notes><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>10</day><month>11</month><year>2008</year></pub-date><volume>3</volume><issue>11</issue><elocation-id>e3688</elocation-id><history><date date-type="received"><day>6</day><month>10</month><year>2008</year></date><date date-type="accepted"><day>23</day><month>10</month><year>2008</year></date></history><copyright-statement>Dashtsoodol et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement><copyright-year>2008</copyright-year><abstract><sec><title>Background</title><p>It is well known that CD1d-restricted V&#x003b1;14 invariant natural killer T (NKT) cells are derived from cells in the CD4<sup>&#x0002b;</sup>CD8<sup>&#x0002b;</sup> double-positive (DP) population in the thymus. However, the developmental progression of NKT cells in the earlier stages remains unclear, and the possible existence of NKT cell presursors in the earlier stages than DP stage remains to be tested.</p></sec><sec><title>Principal Findings</title><p>Here, we demonstrate that NKT cell precursors that express invariant <italic>V&#x003b1;14-J&#x003b1;18</italic> transcripts but devoid of surface expression of the invariant V&#x003b1;14 receptor are present in the late CD4<sup>&#x02212;</sup>CD8<sup>&#x02212;</sup> double-negative (DN)4 stage and have the potential to generate mature NKT cells in both <italic>in vivo</italic> and <italic>in vitro</italic> experimental conditions. Moreover, the DN4 population in CD1d knock-out (CD1dKO) mice was similar to those with an NKT cell potential in wild-type (WT) C57BL/6 (B6) mice, but failed to develop into NKT cells <italic>in vitro</italic>. However, these precursors could develop into NKT cells when co-cultured with normal thymocytes or in an <italic>in vivo</italic> experimental setting, indicating that functional NKT cell precursors are present in CD1dKO mice.</p></sec><sec><title>Conclusions</title><p>Together, these results demonstrate that thymic DN4 fraction contains NKT cell precursors. Our findings provide new insights into the early development of NKT cells prior to surface expression of the invariant V&#x003b1;14 antigen receptor and suggest the possible alternative developmental pathway of NKT cells.</p></sec></abstract><counts><page-count count="7"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>The developmental progression of the T cell lineage in the thymus is precisely controlled, beginning with the early T cell precursors, which present in the population of lineage (Lin)<sup>&#x02212;</sup>, CD4<sup>&#x02212;</sup>CD8<sup>&#x02212;</sup> double-negative (DN) thymocytes. The DN population in the thymus can be further divided based on their expression of CD25 and CD44 into DN1 (CD25<sup>&#x02212;</sup> CD44<sup>&#x0002b;</sup>), DN2 (CD25<sup>&#x0002b;</sup> CD44<sup>&#x0002b;</sup>), DN3 (CD25<sup>&#x0002b;</sup> CD44<sup>&#x02212;</sup>) and DN4 (CD25<sup>&#x02212;</sup> CD44<sup>&#x02212;</sup>), which are sequential developmental stages <xref ref-type="bibr" rid="pone.0003688-Godfrey1">&#x0005b;1&#x0005d;</xref>. Major commitment events to the &#x003b1;&#x003b2; T cell lineage occur at the DN3 stage, where rearrangement of the T cell receptor (TCR) &#x003b2; chain gene (<italic>Tcrb</italic>) and subsequent beta-selection for a functional TCR&#x003b2; chain take place. The cells that survive beta-selection develop into the DN4 stage to become CD4<sup>&#x0002b;</sup>CD8<sup>&#x0002b;</sup> double-positive (DP) thymocytes. In the case of conventional &#x003b1;&#x003b2; T cells, rearrangement of the TCR&#x003b1; chain gene locus occurs at the DP stage, and those cells that make productive rearrangements undergo MHC-mediated positive and negative selection to generate single-positive (SP) CD4 or CD8 T cells <xref ref-type="bibr" rid="pone.0003688-vonBoehmer1">&#x0005b;2&#x0005d;</xref>.</p><p>Natural killer T (NKT) cells are characterized by the expression of an invariant antigen receptor encoded by <italic>V&#x003b1;14-J&#x003b1;18</italic> in mice and <italic>V&#x003b1;24-J&#x003b1;18</italic> in humans. This receptor is used preferentially by NKT cells but not by conventional T cells, defining NKT cells as a distinct lineage from conventional T cells <xref ref-type="bibr" rid="pone.0003688-Taniguchi1">&#x0005b;3&#x0005d;</xref>. NKT cells recognize self- or non-self glycolipid ligands in conjunction with the monomorphic MHC-like molecule CD1d <xref ref-type="bibr" rid="pone.0003688-Brigl1">&#x0005b;4&#x0005d;</xref>, and mediate intermediary functions that link the innate and acquired immune systems, regulating protective and regulatory responses by their rapid secretion of large amounts of cytokines such as IL-4, and IFN-&#x003b3; after activation <xref ref-type="bibr" rid="pone.0003688-Taniguchi2">&#x0005b;5&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003688-Bendelac1">&#x0005b;6&#x0005d;</xref>.</p><p>Since the discovery of this unique cell lineage, the developmental pathway of NKT cells has been one of the most intriguing topics. Based on previous findings that cells with NKT cell potential can be detected in the DP thymocyte population <xref ref-type="bibr" rid="pone.0003688-Gapin1">&#x0005b;7&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003688-Egawa1">&#x0005b;8&#x0005d;</xref>, NKT cells have been thought to branch off from conventional &#x003b1;&#x003b2; T cell precursors at the DP stage in the thymus, where the cells in the DP thymocyte pool expressing a rearranged invariant V&#x003b1;14-J&#x003b1;18 TCR are positively selected by CD1d<sup>&#x0002b;</sup> thymocytes <xref ref-type="bibr" rid="pone.0003688-Bendelac1">&#x0005b;6&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0003688-Bezbradica1">&#x0005b;10&#x0005d;</xref>. However, currently available data do not rule out the possibility that NKT cells are derived from a precursor population distinct from that of conventional &#x003b1;&#x003b2; T cells. Findings in support of independent origins for conventional T and NKT cells include the detection of invariant <italic>V&#x003b1;14-J&#x003b1;18</italic> transcripts before thymus formation in fetal (RAG-1-KO&#x000d7;WT)F1 mice, in which the possibility of contamination with maternal NKT cells in the samples tested is formally excluded <xref ref-type="bibr" rid="pone.0003688-Makino1">&#x0005b;11&#x0005d;</xref>, and the cell surface expression by NKT precursor cells and NKT cells of the granulocyte-macrophage colony stimulating factor (GM-CSF) receptor <xref ref-type="bibr" rid="pone.0003688-Sato1">&#x0005b;12&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003688-Bezbradica2">&#x0005b;13&#x0005d;</xref>, which is a unique marker for myeloid but not lymphoid lineage cells. Considering their unique characteristics compared with conventional T cells, it seemed possible to us that NKT cell precursors might differ from those of conventional T cells and exist at earlier stages than the DP stage previously defined by fate-mapping studies <xref ref-type="bibr" rid="pone.0003688-Egawa1">&#x0005b;8&#x0005d;</xref>. To test this possibility, we focused on cells with NKT cell potential at early stages of development, prior to the DP stage in the thymus.</p><p>In the present study, we demonstrate that NKT cell precursors are present in DN4 stage thymocytes and have the potential to give rise to mature NKT cells in both <italic>in vivo</italic> and <italic>in vitro</italic> experimental settings. Our findings provide new insights into the early development of NKT cells before expression of the invariant V&#x003b1;14-J&#x003b1;18 antigen receptor.</p></sec><sec id="s2"><title>Results and Discussion</title><sec id="s2a"><title>Invariant <italic>V&#x003b1;14-J&#x003b1;18</italic> transcripts are present in the thymic DN4 fraction</title><p>To investigate whether the DN population in the thymus contains cells with NKT cell potential, we first purified Lin<sup>&#x02212;</sup> DN3 and DN4 thymocyte fractions devoid of Lin marker positive mature cells, including NKT cells, by a three-step cell purification method. In the first step, the DN fraction was enriched by depletion of DP and SP thymocytes by magnetic-activated cell sorting (MACS) using microbeads coated with anti-CD4 and anti-CD8 monoclonal antibodies (mAbs). Then the DN enriched fraction was stained with a biotin-labeled Lin mAb &#x02018;cocktail&#x02019; (anti-B220, CD3&#x003b5;, CD11b, CD11c, CD19, Gr-1, TER-119, TCR&#x003b2;, TCR&#x003b3;&#x003b4;) and subsequently reacted with streptavidin microbeads to deplete Lin<sup>&#x0002b;</sup> cells using MACS columns. The resulting Lin<sup>&#x02212;</sup> cells in the eluate fraction were sorted by staining with fluorescent-conjugated streptavidin and also with directly labeled mAbs (anti-CD4, CD8&#x003b1;, TCR&#x003b2;, TCR&#x003b3;&#x003b4;, NK1.1) together with &#x003b1;-galactosylceramide-loaded CD1d (&#x003b1;GC/CD1d) dimer which specifically detects NKT cells <xref ref-type="bibr" rid="pone.0003688-Matsuda1">&#x0005b;14&#x0005d;</xref> to remove any unstained NKT cells and Lin<sup>&#x0002b;</sup> cells left in the samples. This rigorous cell preparation method and staining protocol was used throughout this study unless otherwise indicated. The Lin<sup>&#x02212;</sup> &#x003b1;GC/CD1d dimer<sup>&#x02212;</sup> DN fraction was further analyzed by the CD25, CD44 bivariate staining pattern, which defines the well-characterized thymocyte differentiation pathway. As shown in <xref ref-type="fig" rid="pone-0003688-g001">Figure 1A (upper panel)</xref>, the DN fraction of B6 mice contain neither DP or SP thymocytes, nor &#x003b1;GC/CD1d dimer<sup>&#x0002b;</sup> NKT cells or Lin<sup>&#x0002b;</sup> cells. When highly purified DN3 and DN4 fractions from C57BL/6 (B6) mice were analyzed by RT-PCR, the bands corresponding to NKT cell-specific <italic>V&#x003b1;14-J&#x003b1;18</italic> sequences were detected in the DN4 but not DN3 fraction (<xref ref-type="fig" rid="pone-0003688-g001">Figure 1B</xref>).</p><fig id="pone-0003688-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0003688.g001</object-id><label>Figure 1</label><caption><title>Isolation of the DN4 thymocytes and gene expression analysis.</title><p>(A) FACS profiles of CD25, CD44 staining of DN thymocytes from B6 and CD1dKO mice. The numbers in FACS plots represent the percentage of cells in the indicated quadrants. DN thymocytes from B6 and CD1dKO mice were enriched by MACS depletion of DP, SP and mature Lin<sup>&#x0002b;</sup> cell types. &#x003b1;GC/CD1d dimer was used to exclude NKT cells from the DN thymocytes and an extensive lineage mAb &#x02018;cocktail&#x02019; (anti-B220, CD3&#x003b5;, CD11b, CD11c, CD19, Gr-1, TER-119, TCR&#x003b2;, TCR&#x003b3;&#x003b4;) was used to remove mature cell types. Dot plots were obtained on a 6-color FACS Aria and are representative of more than six independent experiments for each group of mice. (B and C) Gene expression profiles of the DN3 and DN4 thymic fractions. All mRNA samples of B6 and CD1dKO mice were normalized to the <italic>Hprt</italic> expression level and analyzed by RT-PCR. Horizontal wedges indicate three-fold serial dilutions of cDNA samples. Total thymocytes from B6 mice were used as positive controls. Data are representative RT-PCR results of four independent experiments for each group of mice.</p></caption><graphic xlink:href="pone.0003688.g001"/></fig><p>Because a fraction of NKT cells in the thymus is DN and CD44<sup>&#x02212;</sup>, it is still possible that the DN fraction isolated by this method may contain mature or immature NKT cells. To exclude this possibility, we isolated the DN4 fraction from the thymus of CD1d knock-out (CD1dKO) mice, in which NKT cells do not exist because of the lack of expression of CD1d as a selection molecule <xref ref-type="bibr" rid="pone.0003688-Chen1">&#x0005b;15&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0003688-Smiley1">&#x0005b;17&#x0005d;</xref>. The fluorescence-activated cell sorter (FACS) profiles of the CD1dKO DN fractions were essentially identical to those obtained from B6 mice (<xref ref-type="fig" rid="pone-0003688-g001">Figure 1A, lower panel</xref>). Notably, results from the RT-PCR analysis of the CD1dKO DN fractions were identical to those from B6 mice, where the DN4 but not DN3 fraction in both mice expressed NKT cell-specific <italic>V&#x003b1;14-J&#x003b1;18</italic> transcripts (<xref ref-type="fig" rid="pone-0003688-g001">Figure 1C</xref>). The identities of the <italic>V&#x003b1;14-J&#x003b1;18</italic> transcripts detected in the DN4 fractions of B6 and CD1dKO mice were confirmed by direct sequencing of the PCR products (data not shown).</p><p>In addition to their expression of invariant <italic>V&#x003b1;14-J&#x003b1;18</italic> transcripts, the DN4 fraction of B6 and CD1dKO mice contained TCR&#x003b2; chain transcripts (<xref ref-type="fig" rid="pone-0003688-g001">Figures 1B and 1C</xref>), suggesting that both invariant <italic>V&#x003b1;14-J&#x003b1;18</italic> and TCR&#x003b2; transcripts are already present in the DN4 stage before the cells reach the DP stage. It is important to note that our present findings do not necessarily contradict the previous report, demonstrating that the invariant <italic>V&#x003b1;14-J&#x003b1;18</italic> transcripts are detectable at the DP stage <xref ref-type="bibr" rid="pone.0003688-Gapin1">&#x0005b;7&#x0005d;</xref>.</p><p>Regarding the possibility of early invariant <italic>V&#x003b1;14-J&#x003b1;18</italic> gene rearrangement in the DN population, it has recently been shown that low level of TCR&#x003b1; chain gene rearrangement in the late DN stage, which was previously considered to represent a transgenic artifact, occurs even under physiological conditions <xref ref-type="bibr" rid="pone.0003688-Aifantis1">&#x0005b;18&#x0005d;</xref>. The present findings support the possibility that the DN4 fraction in the thymus contains precursors for the NKT cell lineage.</p></sec><sec id="s2b"><title>Gene expression profile and surface phenotype of the DN4 thymic fraction</title><p>To further characterize the DN4 population in the thymus, we used RT-PCR to investigate the expression of genes relevant to the NKT cell development. As shown in <xref ref-type="fig" rid="pone-0003688-g001">Figures 1B and 1C</xref>, both B6 and CD1dKO DN4 cells, as well as DN3 cells used as positive controls, expressed transcripts encoding RAG-1/RAG-2, which are required for the rearrangement of TCR gene segments. They also expressed transcripts for pT&#x003b1; (<italic>Ptcra</italic>), which is required for the NKT cell development in a cell autonomous manner <xref ref-type="bibr" rid="pone.0003688-Benlagha1">&#x0005b;19&#x0005d;</xref>. The thymus-specific isoform of retinoic acid receptor-related orphan receptor &#x003b3; (ROR&#x003b3;t) appears to be required for the rearrangement of the <italic>V&#x003b1;14-J&#x003b1;18</italic> gene segments as it was shown that ROR&#x003b3;t-deficient mice lack <italic>V&#x003b1;14-J&#x003b1;18</italic> transcripts and consequently are deficient in NKT cells <xref ref-type="bibr" rid="pone.0003688-Egawa1">&#x0005b;8&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003688-Bezbradica1">&#x0005b;10&#x0005d;</xref>. As shown in <xref ref-type="fig" rid="pone-0003688-g001">Figures 1B and 1C</xref>, ROR&#x003b3;t transcripts were clearly detected in the DN4 fraction, and to a lesser extent in the DN3 fraction in both B6 and CD1dKO mice.</p><p>Considering that DP thymocytes exclusively express ROR&#x003b3;t and using the ROR&#x003b3;t-Cre fate-mapping method, it has been concluded that all NKT cells and &#x003b1;&#x003b2; T cells are derived from DP thymocyte precursors <xref ref-type="bibr" rid="pone.0003688-Egawa1">&#x0005b;8&#x0005d;</xref>. Our data (<xref ref-type="fig" rid="pone-0003688-g001">Figures 1B and 1C</xref>) and those of others <xref ref-type="bibr" rid="pone.0003688-Villey1">&#x0005b;20&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003688-He1">&#x0005b;21&#x0005d;</xref> clearly demonstrate that ROR&#x003b3;t expression begins at the DN3 stage, presumably as a result of pre-TCR signaling. Moreover, the recent report that not all &#x003b1;&#x003b2; T cells develop through the DP stage <xref ref-type="bibr" rid="pone.0003688-Aifantis1">&#x0005b;18&#x0005d;</xref> supports the possibility that some of NKT cells are not derived from DP precursors.</p><p>Next, we analyzed the surface phenotype of the DN4 thymic fraction from both B6 and CD1dKO mice. In contrast to &#x003b1;GC/CD1d dimer<sup>&#x0002b;</sup> NKT cells in the thymus, which are CD24<sup>low</sup> CD62L<sup>&#x02212;</sup> CD69<sup>&#x0002b;</sup> and CD122<sup>&#x0002b;</sup>, both B6 and CD1dKO &#x003b1;GC/CD1d dimer<sup>&#x02212;</sup> DN4 populations were uniformly CD24<sup>high</sup>, CD62L<sup>&#x0002b;</sup>, CD69<sup>&#x02212;</sup>, and CD122<sup>&#x02212;</sup> (<xref ref-type="supplementary-material" rid="pone.0003688.s001">Figure S1</xref>). Thus, the DN4 population is different from the &#x003b1;GC/CD1d dimer<sup>&#x0002b;</sup> NKT cells in terms of cell surface phenotype.</p><p>It is well established that the earliest detectable NKT cell precursors just after positive-selection with CD1d in the thymus, which are &#x003b1;GC/CD1d tetramer<sup>&#x0002b;</sup>, have NK1.1<sup>&#x02212;</sup>, CD4<sup>&#x0002b;</sup>, CD8<sup>&#x0002b;/&#x02212;</sup>, CD24<sup>&#x0002b;</sup>, CD44<sup>low</sup> and CD69<sup>&#x0002b;</sup> surface phenotype <xref ref-type="bibr" rid="pone.0003688-Godfrey2">&#x0005b;22&#x0005d;</xref>. Given our findings that the DN4 fraction lacked expression of the cell surface invariant V&#x003b1;14 receptor (<xref ref-type="fig" rid="pone-0003688-g001">Figure 1A</xref>) and CD69 (<xref ref-type="supplementary-material" rid="pone.0003688.s001">Figure S1</xref>), but possessed the NKT cell-specific <italic>V&#x003b1;14-J&#x003b1;18</italic> transcripts in CD1dKO mice (<xref ref-type="fig" rid="pone-0003688-g001">Figure 1C</xref>), we considered that the DN4 population contains the <italic>bona fide</italic> precursors to NKT cells prior to positive-selection with CD1d in the thymus.</p></sec><sec id="s2c"><title><italic>In vitro</italic> generation of NKT cells from the DN4 fraction</title><p>To determine whether the DN4 fraction, which expresses <italic>V&#x003b1;14-J&#x003b1;18</italic> transcripts but no cell surface TCR, has NKT cell precursor potential, we co-cultured the DN4 population with OP9 stromal cells engineered to express Notch ligand delta-like 1 (OP9/Dll-1) that support conventional T cell differentiation <italic>in vitro</italic><xref ref-type="bibr" rid="pone.0003688-Schmitt1">&#x0005b;23&#x0005d;</xref>. Although the developmental requirements of NKT cells might differ from those of conventional T cells, the OP9/Dll-1 stromal monolayer culture system was chosen because of its ability to promote the survival of immature T cells <xref ref-type="bibr" rid="pone.0003688-Ciofani1">&#x0005b;24&#x0005d;</xref>.</p><p>Highly purified (&#x02265;99&#x00025;) DN4 cells from either B6 or CD1dKO mice (<xref ref-type="fig" rid="pone-0003688-g001">Figures 1A</xref> and <xref ref-type="supplementary-material" rid="pone.0003688.s002">S2</xref>) were co-cultured with OP9/Dll-1 in the presence of IL-2, IL-7, and IL-15, as these cytokines are known to have an important role in NKT cell homeostasis <xref ref-type="bibr" rid="pone.0003688-Matsuda2">&#x0005b;25&#x0005d;</xref>. After 8 to 10 days of culture, the DN4 cells from B6 mice, but not those from CD1dKO mice, successfully generated &#x003b1;GC/CD1d dimer<sup>&#x0002b;</sup> NKT cells (<xref ref-type="fig" rid="pone-0003688-g002">Figure 2A</xref>).</p><fig id="pone-0003688-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0003688.g002</object-id><label>Figure 2</label><caption><title><italic>In vitro</italic> generation of &#x003b1;GC/CD1d dimer<sup>&#x0002b;</sup> NKT cells from the DN4 thymic population.</title><p>(A) <italic>In vitro</italic> generation of &#x003b1;GC/CD1d dimer<sup>&#x0002b;</sup> NKT cells. Thymic DN4 fractions from B6 or CD1dKO mice were co-cultured with OP9/Dll-1 for 8 to 10 days as described in <xref ref-type="sec" rid="s3">Materials and Methods</xref>. The numbers are the percentages of &#x003b1;GC/CD1d dimer<sup>&#x0002b;</sup> NKT cells within the PI<sup>&#x02212;</sup> CD45<sup>&#x0002b;</sup> viable lymphocyte gate. Representative data from three independent experiments for each group of mice are shown. (B) Mixed co-culture of CD1dKO DN4 with WT DN4 fractions. Thymic DN4 fractions from B6.CD45.1 and CD1dKO (CD45.2<sup>&#x0002b;</sup>) mice were mixed at a ratio of 7&#x02236;3, and cultured for 8 days on OP9/Dll-1. Values indicate the percentage of &#x003b1;GC/CD1d dimer<sup>&#x0002b;</sup> NKT cells within CD45.2<sup>&#x0002b;</sup> or CD45.2<sup>&#x02212;</sup> gated viable lymphocytes. APC-conjugated &#x003b1;GC/CD1d dimer and anti-APC microbeads were used to enrich NKT cells by MACS. Representative data from three independent experiments are shown.</p></caption><graphic xlink:href="pone.0003688.g002"/></fig><p>To formally exclude the possibility of contamination of our culture system with mature NKT cells and to confirm the presence of NKT cell precursors in the DN4 fraction of CD1dKO mice, we mixed the DN4 fraction from B6.CD45.1 congenic mice with the DN4 fraction from CD1dKO mice at 7&#x02236;3 ratio, and then co-cultured with OP9/Dll-1. The CD1dKO DN4 cells, identified as CD45.2<sup>&#x0002b;</sup>, were able to generate &#x003b1;GC/CD1d dimer<sup>&#x0002b;</sup> NKT cells in the presence of WT CD1d<sup>&#x0002b;</sup>/CD45.1<sup>&#x0002b;</sup> thymocytes in the 8 day-culture (<xref ref-type="fig" rid="pone-0003688-g002">Figure 2B</xref>). These results, together with the data shown in <xref ref-type="fig" rid="pone-0003688-g001">Figure 1C</xref>, clearly demonstrated the presence of NKT precursors in the DN4 population. In addition, the results shown in <xref ref-type="fig" rid="pone-0003688-g002">Figure 2B</xref> confirmed the requirement for CD1d-expressing thymocytes for the development of NKT cells, in agreement with previous reports <xref ref-type="bibr" rid="pone.0003688-Bendelac2">&#x0005b;9&#x0005d;</xref>.</p></sec><sec id="s2d"><title>Phenotype and cytokine secretion profile of NKT cells generated <italic>in vitro</italic> from DN4 thymic fraction</title><p>FACS analysis shown in <xref ref-type="fig" rid="pone-0003688-g003">Figure 3A</xref> revealed that the most &#x003b1;GC/CD1d dimer<sup>&#x0002b;</sup> NKT cells generated <italic>in vitro</italic> from the B6 DN4 population were of the NK1.1<sup>&#x02212;</sup>, DN, and CD44<sup>&#x0002b;</sup> phenotype, while <italic>ex vivo</italic> B6 thymic NKT cells were of the NK1.1<sup>&#x0002b;</sup>, CD4<sup>&#x0002b;</sup> or DN, and CD44<sup>&#x0002b;</sup> phenotype. A standard cytokine secretion assay using &#x003b1;-galactosylceramide (&#x003b1;GalCer)-pulsed GM-CSF-induced bone marrow-derived dendritic cells (GM-DC) demonstrated that the <italic>in vitro</italic> derived NKT cells secreted both IFN-&#x003b3; and IL-4 in a CD1d-dependent manner, which is the hallmark of NKT cells (<xref ref-type="fig" rid="pone-0003688-g003">Figure 3B</xref>). Of note, the cytokine secretion profiles of the <italic>in vitro</italic> generated NKT cells were more of Th1-type, with very little IL-4, compared with their <italic>ex vivo</italic> counterparts (<xref ref-type="fig" rid="pone-0003688-g003">Figure 3B</xref>). These differences between <italic>in vitro</italic> generated NKT cells and <italic>ex vivo</italic> thymic NKT cells may be due to the limits of the OP9/Dll-1 culture system, which has been reported to support the preferential development of IFN-&#x003b3; producing CD8 T cells <xref ref-type="bibr" rid="pone.0003688-Schmitt1">&#x0005b;23&#x0005d;</xref>, and may also indicate a requirement for the intact thymic microenvironment for the full differentiation of NKT cells <xref ref-type="bibr" rid="pone.0003688-Nakagawa1">&#x0005b;26&#x0005d;</xref>. It was also reported that human DN NKT cells show Th1-type biased cytokine response upon stimulation <xref ref-type="bibr" rid="pone.0003688-Lee1">&#x0005b;27&#x0005d;</xref>. Collectively, the data shown in <xref ref-type="fig" rid="pone-0003688-g003">Figures 3A and 3B</xref> suggest that the <italic>in vitro</italic> generated NKT cells resemble those found <italic>in vivo</italic>.</p><fig id="pone-0003688-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0003688.g003</object-id><label>Figure 3</label><caption><title>Cell surface phenotype and cytokine production of <italic>in vitro</italic> generated NKT cells.</title><p>(A) FACS profiles of <italic>in vitro</italic> generated NKT cells. The expression of NK1.1, CD4, CD8 and CD44 antigens by NKT cells generated <italic>in vitro</italic> from B6 DN4 thymocytes on day 10 of culture are compared to those of <italic>ex vivo</italic> B6 thymic NKT cells. Viable &#x003b1;GC/CD1d dimer<sup>&#x0002b;</sup> NKT cells were gated for the analysis. Representative data from three independent experiments are shown. (B) Cytokine secretion profiles of <italic>in vitro</italic> generated NKT cells. &#x003b1;GC/CD1d dimer<sup>&#x0002b;</sup> NKT cells generated <italic>in vitro</italic> from B6 DN4 thymocytes cultured on OP9/Dll-1 were FACS sorted on day 10 of culture, as shown in <xref ref-type="fig" rid="pone-0003688-g002">Figure 2A</xref>, and co-cultured with &#x003b1;GalCer-pulsed GM-DCs from either B6 or CD1dKO mice. APC-conjugated &#x003b1;GC/CD1d dimer and anti-APC microbeads were used to enrich NKT cells by MACS. The supernatants were collected after 48 hours of culture and were assayed for IL-4 and IFN-&#x003b3; levels using the CBA method. Freshly sorted B6 thymic NKT cells served as positive controls. Values are expressed as mean&#x000b1;SD from three independent experiments. ND, not detected.</p></caption><graphic xlink:href="pone.0003688.g003"/></fig></sec><sec id="s2e"><title><italic>In vivo</italic> generation of NKT cells from DN4 thymocytes</title><p>To further substantiate and confirm our findings in <xref ref-type="fig" rid="pone-0003688-g002">Figure 2B</xref>, showing that CD1dKO DN4 population contains cells with NKT cell potential, highly purified DN4 cells from CD1dKO (CD45.2<sup>&#x0002b;</sup>) mice were injected intrathymically into B6.CD45.1-congenic recipients.</p><p>As demonstrated in <xref ref-type="fig" rid="pone-0003688-g004">Figure 4A</xref>, transfer of CD45.2<sup>&#x0002b;</sup> CD1dKO-derived DN4 donor cells successfully generated &#x003b1;GC/CD1d dimer<sup>&#x0002b;</sup> NKT cells in the WT CD45.1 recipient thymus. The surface phenotype of these <italic>in vivo</italic> generated &#x003b1;GC/CD1d dimer<sup>&#x0002b;</sup> NKT cells from CD1dKO donors resembled that of resident NKT cells in the WT recipients, where the majority of NKT cells were NK1.1<sup>&#x0002b;</sup> and CD44<sup>&#x0002b;</sup> (<xref ref-type="fig" rid="pone-0003688-g004">Figure 4B</xref>). These results demonstrated that the DN4 thymocytes from CD1dKO mice contained precursors of NKT cells, which is consistent with the presence of the invariant <italic>V&#x003b1;14-J&#x003b1;18</italic> transcripts in this population (<xref ref-type="fig" rid="pone-0003688-g001">Figure 1C</xref>), and the potential of these cells to give rise to NKT cells when cultured <italic>in vitro</italic> (<xref ref-type="fig" rid="pone-0003688-g002">Figure 2B</xref>).</p><fig id="pone-0003688-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0003688.g004</object-id><label>Figure 4</label><caption><title>Generation of &#x003b1;GC/CD1d dimer<sup>&#x0002b;</sup> NKT cells <italic>in vivo</italic> by intrathymic injection of CD1dKO DN4 thymocytes.</title><p>(A) Detection of &#x003b1;GC/CD1d dimer<sup>&#x0002b;</sup> NKT cells in the thymus. FACS sorted DN4 thymocytes (6&#x000d7;10<sup>5</sup>) from CD1dKO mice were injected intrathymically into B6.CD45.1 congenic mice, and recipient mice were analyzed 3 weeks later by FACS. Numbers on FACS plots indicate the percentage of cells in the indicated gates. Anti-CD45.2 staining was used to distinguish between cells of donor and recipient origin. APC-conjugated &#x003b1;GC/CD1d dimer and anti-APC microbeads were used to enrich NKT cells by MACS. (B) FACS profiles of &#x003b1;GC/CD1d dimer<sup>&#x0002b;</sup> NKT cells generated by intrathymic injection of CD1dKO DN4 thymocytes. Histogram plots show the expression of NK1.1, CD4 and CD44 by <italic>in vivo</italic> generated NKT cells from CD45.2<sup>&#x0002b;</sup> CD1dKO DN4 thymocytes compared with resident NKT cells of CD45.2<sup>&#x02212;</sup> B6.CD45.1 host mice. Staining controls are shown in gray. The data is representative of two independent experiments.</p></caption><graphic xlink:href="pone.0003688.g004"/></fig><p>Taken together, we have identified cells in the thymic DN4 population with NKT cell potential in both <italic>in vitro</italic> and <italic>in vivo</italic> experimental settings. Studies to elucidate the differentiation pathway(s) of NKT cells should provide further insights into NKT cell biology and provide clues to solve the puzzles concerning developmental requirements of this unique cell lineage.</p></sec></sec><sec sec-type="materials|methods" id="s3"><title>Materials and Methods</title><sec id="s3a"><title>Mice</title><p>B6 mice were purchased from CLEA Japan, CD1dKO mice with B6 genetic background were from L. Van Kaer (Vanderbilt University, Nashville, TN) and B6.CD45.1 mice were from The Jackson Laboratory. Mice were maintained under specific pathogen-free conditions in the animal facility of the RIKEN Research Center for Allergy and Immunology and were used at 5&#x02013;8 weeks of age unless otherwise indicated. All experiments were in accordance with protocols approved by the RIKEN Animal Care and Use Committee.</p></sec><sec id="s3b"><title>Flow cytometry and cell sorting</title><p>mAbs specific for B220 (RA3-6B2), CD3&#x003b5; (145-2C11), CD4 (RM4-5) (GK1.5), CD8&#x003b1; (53-6.7), CD11b (M1/70), CD11c (HL3) CD19 (1D3), CD24 (M1/69), CD25 (PC61), CD44 (IM7), CD45 (30-F11), CD45.2 (104), CD62L (MEL-14), CD69 (H1.2F3), CD122 (TM-b1), Gr-1 (RB6-8C5), NK1.1 (PK136), TCR&#x003b2; (H57-597), TCR&#x003b3;&#x003b4; (GL3), TER-119 and isotype controls were purchased from BD Biosciences or eBioscience, and used as FITC, PE, PerCP-Cy5.5, PE-Cy7, APC, APC-Cy7, or Pacific Blue conjugates. &#x003b1;GalCer- or vehicle-loaded soluble dimeric mouse CD1d:Ig fusion protein (BD Biosciences) was used together with APC-anti-mouse IgG<sub>1</sub> (X56; BD Biosciences) mAb to stain NKT cells. Cell preparation and staining were performed as described <xref ref-type="bibr" rid="pone.0003688-Watarai1">&#x0005b;28&#x0005d;</xref>. Propidium iodide (PI) (Sigma-Aldrich) was added to the cell suspension immediately before analysis to gate out dead cells where indicated. Flow cytometry was done on a FACS Calibur or FACS Aria (BD Biosciences). Data were analyzed with FlowJo (Tree Star).</p><p>DN thymocytes were enriched from total thymocytes by depletion of CD4<sup>&#x0002b;</sup>, CD8<sup>&#x0002b;</sup> thymocytes using anti-mouse CD4 and CD8 microbeads and MACS LS columns according to the manufacturer's protocol (Miltenyi Biotec). APC-conjugated &#x003b1;GC/CD1d dimer and anti-APC microbeads were used to enrich NKT cells by MACS where indicated. Cells were sorted using FACS Aria. Sorted cells were generally &#x02267;99&#x00025; pure as determined by post-sort analysis using FACS.</p></sec><sec id="s3c"><title>OP9/Dll-1 co-cultures</title><p>OP9/Dll-1 cells were generated by H. Kawamoto and were maintained as described <xref ref-type="bibr" rid="pone.0003688-Schmitt1">&#x0005b;23&#x0005d;</xref>. Sorted DN4 thymocytes (6&#x000d7;10<sup>5</sup>) were plated onto a 10 cm tissue culture plate (BD Falcon) containing a monolayer of OP9/Dll-1 cells seeded at 3.5&#x000d7;10<sup>5</sup> cells/dish on the previous day. Co-cultures were done in the presence of 5 ng/ml of each IL-2, IL-7 (R&#x00026;D Systems) and IL-15 (Peprotech). Cells were transferred onto a fresh monolayer on day 5 of culture and analyzed at the indicated time points.</p></sec><sec id="s3d"><title>RT-PCR</title><p>Total RNA was prepared from sorted thymocyte populations (5&#x000d7;10<sup>5</sup>) using the RNeasy kit (Qiagen) and treated with DNase (Qiagen). cDNA was synthesized with SuperScript III reverse transcriptase, oligo(dT) and RNaseOut followed by treatment with RNase H (Invitrogen). The list of primer pairs used in RT-PCR is shown in <xref ref-type="supplementary-material" rid="pone.0003688.s003">Table S1</xref>. The numbers of PCR cycles were as follows: 26 for <italic>Ptcra</italic>; 28 for <italic>Tcrb-C</italic>; 29 for <italic>Hprt</italic> and <italic>Rag-1</italic>; 30 for <italic>Rag-2</italic>; 32 for <italic>Rorgt</italic>; 39 for <italic>V&#x003b1;14-J&#x003b1;18</italic>. The amplified products were stained with SYBR Safe DNA gel stain (Molecular Probes) and visualized using a LAS-1000 lumino image analyzer (Fuji Film, Japan). The identity of RT-PCR generated <italic>V&#x003b1;14-J&#x003b1;18</italic> bands was confirmed by direct sequencing using an ABI 3100<italic>xl</italic> genetic analyzer.</p></sec><sec id="s3e"><title>Cytokine measurement</title><p>GM-DC were prepared from B6 and CD1dKO mice and pulsed overnight with 100 ng/ml of &#x003b1;GalCer. NKT cells (2&#x000d7;10<sup>4</sup>) from either B6 thymus or <italic>in vitro</italic> DN4 culture origin were plated with an equal number of GM-DC in 96-well U-bottom plates (BD Falcon) in a 0.1 ml volume. Culture supernatants were harvested after 48 hours of culture and assayed for IL-4 and IFN-&#x003b3; levels with cytokine beads array (CBA) Flex Set (BD Bioscience) using a FACS Calibur. Resulting data were analyzed with the FCAP Array software (Soft Flow).</p></sec><sec id="s3f"><title>Intrathymic injection</title><p>B6.CD45.1 recipient mice received a slight whole body &#x003b3;-irradiation (3 Gy) from a cesium source (Gammacell 40). Mice were injected intrathymically with FACS sorted DN4 thymocytes (6&#x000d7;10<sup>5</sup>) in a 10 &#x000b5;l volume using a Hamilton syringe fitted with a 33G needle. Recipient mice were analyzed 3 weeks after injection.</p></sec></sec><sec sec-type="supplementary-material" id="s4"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0003688.s001"><label>Figure S1</label><caption><p>Cell surface phenotypes of DN4 thymocytes. Histogram plots show the expression of CD24, CD62L, CD69 and CD122 antigens by DN4 thymocytes gated as shown in <xref ref-type="fig" rid="pone-0003688-g001">Figure 1A</xref> from B6 (black) and CD1dKO (blue) mice compared to those of B6 thymic &#x003b1;GC/CD1d dimer<sup>&#x0002b;</sup> NKT cells (red). 7-color FACS analysis was performed using a FACS Aria. Staining controls are shown in gray. Representative data of three independent experiments are shown.</p><p>(1.35 MB TIF)</p></caption><media xlink:href="pone.0003688.s001.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0003688.s002"><label>Figure S2</label><caption><p>Post-sort purity of FACS sorted DN4 thymocytes. Post-sort analysis of FACS sorted DN4 thymocytes from B6 and CD1dKO mice. Numbers are the percentage of cells in the indicated quadrants. Representative data from more than six independent experiments are shown.</p><p>(0.46 MB TIF)</p></caption><media xlink:href="pone.0003688.s002.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0003688.s003"><label>Table S1</label><caption><p>Oligonucleotide sequences for primer pairs used in PCR amplifications.</p><p>(0.04 MB DOC)</p></caption><media xlink:href="pone.0003688.s003.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We would like to thank H. Kawamoto (RIKEN, RCAI) for OP9/Dll-1 cells. We also would like to thank L. Van Kaer (Vanderbilt University, Nashville, TN) for providing with CD1dKO mice. We are grateful to Y. Nagata, N. Hongo, E. Sekine, S. Inoue and A. Terashima for technical support, and to N. Takeuchi for secretarial assistance.</p></ack><ref-list><title>References</title><ref id="pone.0003688-Godfrey1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Godfrey</surname><given-names>DI</given-names></name><name><surname>Zlotnik</surname><given-names>A</given-names></name></person-group><year>1993</year><article-title>Control points in early T-cell development.</article-title><source>Immunol Today</source><volume>14</volume><fpage>547</fpage><lpage>553</lpage><pub-id pub-id-type="pmid">7903854</pub-id></citation></ref><ref id="pone.0003688-vonBoehmer1"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>von Boehmer</surname><given-names>H</given-names></name></person-group><year>2004</year><article-title>Selection of the T-cell repertoire: receptor-controlled checkpoints in T-cell development.</article-title><source>Adv Immunol</source><volume>84</volume><fpage>201</fpage><lpage>238</lpage><pub-id pub-id-type="pmid">15246254</pub-id></citation></ref><ref id="pone.0003688-Taniguchi1"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Taniguchi</surname><given-names>M</given-names></name><name><surname>Harada</surname><given-names>M</given-names></name><name><surname>Kojo</surname><given-names>S</given-names></name><name><surname>Nakayama</surname><given-names>T</given-names></name><name><surname>Wakao</surname><given-names>H</given-names></name></person-group><year>2003</year><article-title>The regulatory role of Valpha14 NKT cells in innate and acquired immune response.</article-title><source>Annu Rev Immunol</source><volume>21</volume><fpage>483</fpage><lpage>513</lpage><pub-id pub-id-type="pmid">12543936</pub-id></citation></ref><ref id="pone.0003688-Brigl1"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brigl</surname><given-names>M</given-names></name><name><surname>Brenner</surname><given-names>MB</given-names></name></person-group><year>2004</year><article-title>CD1: antigen presentation and T cell function.</article-title><source>Annu Rev Immunol</source><volume>22</volume><fpage>817</fpage><lpage>890</lpage><pub-id pub-id-type="pmid">15032598</pub-id></citation></ref><ref id="pone.0003688-Taniguchi2"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Taniguchi</surname><given-names>M</given-names></name><name><surname>Seino</surname><given-names>K</given-names></name><name><surname>Nakayama</surname><given-names>T</given-names></name></person-group><year>2003</year><article-title>The NKT cell system: bridging innate and acquired immunity.</article-title><source>Nat Immunol</source><volume>4</volume><fpage>1164</fpage><lpage>1165</lpage><pub-id pub-id-type="pmid">14639465</pub-id></citation></ref><ref id="pone.0003688-Bendelac1"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bendelac</surname><given-names>A</given-names></name><name><surname>Savage</surname><given-names>PB</given-names></name><name><surname>Teyton</surname><given-names>L</given-names></name></person-group><year>2007</year><article-title>The Biology of NKT Cells.</article-title><source>Annu Rev Immunol</source><volume>25</volume><fpage>297</fpage><lpage>336</lpage><pub-id pub-id-type="pmid">17150027</pub-id></citation></ref><ref id="pone.0003688-Gapin1"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gapin</surname><given-names>L</given-names></name><name><surname>Matsuda</surname><given-names>JL</given-names></name><name><surname>Surh</surname><given-names>CD</given-names></name><name><surname>Kronenberg</surname><given-names>M</given-names></name></person-group><year>2001</year><article-title>NKT cells derive from double-positive thymocytes that are positively selected by CD1d.</article-title><source>Nat Immunol</source><volume>2</volume><fpage>971</fpage><lpage>978</lpage><pub-id pub-id-type="pmid">11550008</pub-id></citation></ref><ref id="pone.0003688-Egawa1"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Egawa</surname><given-names>T</given-names></name><name><surname>Eberl</surname><given-names>G</given-names></name><name><surname>Taniuchi</surname><given-names>I</given-names></name><name><surname>Benlagha</surname><given-names>K</given-names></name><name><surname>Geissmann</surname><given-names>F</given-names></name><etal/></person-group><year>2005</year><article-title>Genetic evidence supporting selection of the Valpha14i NKT cell lineage from double-positive thymocyte precursors.</article-title><source>Immunity</source><volume>22</volume><fpage>705</fpage><lpage>716</lpage><pub-id pub-id-type="pmid">15963785</pub-id></citation></ref><ref id="pone.0003688-Bendelac2"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bendelac</surname><given-names>A</given-names></name></person-group><year>1995</year><article-title>Positive selection of mouse NK1&#x0002b; T cells by CD1-expressing cortical thymocytes.</article-title><source>J Exp Med</source><volume>182</volume><fpage>2091</fpage><lpage>2096</lpage><pub-id pub-id-type="pmid">7500054</pub-id></citation></ref><ref id="pone.0003688-Bezbradica1"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bezbradica</surname><given-names>JS</given-names></name><name><surname>Hill</surname><given-names>T</given-names></name><name><surname>Stanic</surname><given-names>AK</given-names></name><name><surname>Van Kaer</surname><given-names>L</given-names></name><name><surname>Joyce</surname><given-names>S</given-names></name></person-group><year>2005</year><article-title>Commitment toward the natural T (iNKT) cell lineage occurs at the CD4&#x0002b;8&#x0002b; stage of thymic ontogeny.</article-title><source>Proc Natl Acad Sci U S A</source><volume>102</volume><fpage>5114</fpage><lpage>5119</lpage><pub-id pub-id-type="pmid">15792999</pub-id></citation></ref><ref id="pone.0003688-Makino1"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Makino</surname><given-names>Y</given-names></name><name><surname>Kanno</surname><given-names>R</given-names></name><name><surname>Koseki</surname><given-names>H</given-names></name><name><surname>Taniguchi</surname><given-names>M</given-names></name></person-group><year>1996</year><article-title>Development of Valpha14&#x0002b; NK T cells in the early stages of embryogenesis.</article-title><source>Proc Natl Acad Sci U S A</source><volume>93</volume><fpage>6516</fpage><lpage>6520</lpage><pub-id pub-id-type="pmid">8692847</pub-id></citation></ref><ref id="pone.0003688-Sato1"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>H</given-names></name><name><surname>Nakayama</surname><given-names>T</given-names></name><name><surname>Tanaka</surname><given-names>Y</given-names></name><name><surname>Yamashita</surname><given-names>M</given-names></name><name><surname>Shibata</surname><given-names>Y</given-names></name><etal/></person-group><year>1999</year><article-title>Induction of differentiation of pre-NKT cells to mature Valpha 14 NKT cells by granulocyte/macrophage colony-stimulating factor.</article-title><source>Proc Natl Acad Sci U S A</source><volume>96</volume><fpage>7439</fpage><lpage>7444</lpage><pub-id pub-id-type="pmid">10377433</pub-id></citation></ref><ref id="pone.0003688-Bezbradica2"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bezbradica</surname><given-names>JS</given-names></name><name><surname>Gordy</surname><given-names>LE</given-names></name><name><surname>Stanic</surname><given-names>AK</given-names></name><name><surname>Dragovic</surname><given-names>S</given-names></name><name><surname>Hill</surname><given-names>T</given-names></name><etal/></person-group><year>2006</year><article-title>Granulocyte-macrophage colony-stimulating factor regulates effector differentiation of invariant natural killer T cells during thymic ontogeny.</article-title><source>Immunity</source><volume>25</volume><fpage>487</fpage><lpage>497</lpage><pub-id pub-id-type="pmid">16949316</pub-id></citation></ref><ref id="pone.0003688-Matsuda1"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matsuda</surname><given-names>JL</given-names></name><name><surname>Naidenko</surname><given-names>OV</given-names></name><name><surname>Gapin</surname><given-names>L</given-names></name><name><surname>Nakayama</surname><given-names>T</given-names></name><name><surname>Taniguchi</surname><given-names>M</given-names></name><etal/></person-group><year>2000</year><article-title>Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers.</article-title><source>J Exp Med</source><volume>192</volume><fpage>741</fpage><lpage>754</lpage><pub-id pub-id-type="pmid">10974039</pub-id></citation></ref><ref id="pone.0003688-Chen1"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>YH</given-names></name><name><surname>Chiu</surname><given-names>NM</given-names></name><name><surname>Mandal</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>CR</given-names></name></person-group><year>1997</year><article-title>Impaired NK1&#x0002b; T cell development and early IL-4 production in CD1-deficient mice.</article-title><source>Immunity</source><volume>6</volume><fpage>459</fpage><lpage>467</lpage><pub-id pub-id-type="pmid">9133425</pub-id></citation></ref><ref id="pone.0003688-Mendiratta1"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mendiratta</surname><given-names>SK</given-names></name><name><surname>Martin</surname><given-names>WD</given-names></name><name><surname>Hong</surname><given-names>S</given-names></name><name><surname>Boesteanu</surname><given-names>A</given-names></name><name><surname>Joyce</surname><given-names>S</given-names></name><etal/></person-group><year>1997</year><article-title>CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4.</article-title><source>Immunity</source><volume>6</volume><fpage>469</fpage><lpage>477</lpage><pub-id pub-id-type="pmid">9133426</pub-id></citation></ref><ref id="pone.0003688-Smiley1"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smiley</surname><given-names>ST</given-names></name><name><surname>Kaplan</surname><given-names>MH</given-names></name><name><surname>Grusby</surname><given-names>MJ</given-names></name></person-group><year>1997</year><article-title>Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells.</article-title><source>Science</source><volume>275</volume><fpage>977</fpage><lpage>979</lpage><pub-id pub-id-type="pmid">9020080</pub-id></citation></ref><ref id="pone.0003688-Aifantis1"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aifantis</surname><given-names>I</given-names></name><name><surname>Bassing</surname><given-names>CH</given-names></name><name><surname>Garbe</surname><given-names>AI</given-names></name><name><surname>Sawai</surname><given-names>K</given-names></name><name><surname>Alt</surname><given-names>FW</given-names></name><etal/></person-group><year>2006</year><article-title>The E delta enhancer controls the generation of CD4- CD8- alphabeta TCR-expressing T cells that can give rise to different lineages of alphabeta T cells.</article-title><source>J Exp Med</source><volume>203</volume><fpage>1543</fpage><lpage>1550</lpage><pub-id pub-id-type="pmid">16754716</pub-id></citation></ref><ref id="pone.0003688-Benlagha1"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Benlagha</surname><given-names>K</given-names></name><name><surname>Wei</surname><given-names>DG</given-names></name><name><surname>Veiga</surname><given-names>J</given-names></name><name><surname>Teyton</surname><given-names>L</given-names></name><name><surname>Bendelac</surname><given-names>A</given-names></name></person-group><year>2005</year><article-title>Characterization of the early stages of thymic NKT cell development.</article-title><source>J Exp Med</source><volume>202</volume><fpage>485</fpage><lpage>492</lpage><pub-id pub-id-type="pmid">16087715</pub-id></citation></ref><ref id="pone.0003688-Villey1"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Villey</surname><given-names>I</given-names></name><name><surname>de Chasseval</surname><given-names>R</given-names></name><name><surname>de Villartay</surname><given-names>JP</given-names></name></person-group><year>1999</year><article-title>RORgammaT, a thymus-specific isoform of the orphan nuclear receptor RORgamma/TOR, is up-regulated by signaling through the pre-T cell receptor and binds to the TEA promoter.</article-title><source>Eur J Immunol</source><volume>29</volume><fpage>4072</fpage><lpage>4080</lpage><pub-id pub-id-type="pmid">10602018</pub-id></citation></ref><ref id="pone.0003688-He1"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>YW</given-names></name><name><surname>Deftos</surname><given-names>ML</given-names></name><name><surname>Ojala</surname><given-names>EW</given-names></name><name><surname>Bevan</surname><given-names>MJ</given-names></name></person-group><year>1998</year><article-title>RORgamma t, a novel isoform of an orphan receptor, negatively regulates Fas ligand expression and IL-2 production in T cells.</article-title><source>Immunity</source><volume>9</volume><fpage>797</fpage><lpage>806</lpage><pub-id pub-id-type="pmid">9881970</pub-id></citation></ref><ref id="pone.0003688-Godfrey2"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Godfrey</surname><given-names>DI</given-names></name><name><surname>Berzins</surname><given-names>SP</given-names></name></person-group><year>2007</year><article-title>Control points in NKT-cell development.</article-title><source>Nat Rev Immunol</source><volume>7</volume><fpage>505</fpage><lpage>518</lpage><pub-id pub-id-type="pmid">17589542</pub-id></citation></ref><ref id="pone.0003688-Schmitt1"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schmitt</surname><given-names>TM</given-names></name><name><surname>Zuniga-Pflucker</surname><given-names>JC</given-names></name></person-group><year>2002</year><article-title>Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro.</article-title><source>Immunity</source><volume>17</volume><fpage>749</fpage><lpage>756</lpage><pub-id pub-id-type="pmid">12479821</pub-id></citation></ref><ref id="pone.0003688-Ciofani1"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ciofani</surname><given-names>M</given-names></name><name><surname>Zuniga-Pflucker</surname><given-names>JC</given-names></name></person-group><year>2005</year><article-title>Notch promotes survival of pre-T cells at the beta-selection checkpoint by regulating cellular metabolism.</article-title><source>Nat Immunol</source><volume>6</volume><fpage>881</fpage><lpage>888</lpage><pub-id pub-id-type="pmid">16056227</pub-id></citation></ref><ref id="pone.0003688-Matsuda2"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matsuda</surname><given-names>JL</given-names></name><name><surname>Gapin</surname><given-names>L</given-names></name><name><surname>Sidobre</surname><given-names>S</given-names></name><name><surname>Kieper</surname><given-names>WC</given-names></name><name><surname>Tan</surname><given-names>JT</given-names></name><etal/></person-group><year>2002</year><article-title>Homeostasis of V alpha 14i NKT cells.</article-title><source>Nat Immunol</source><volume>3</volume><fpage>966</fpage><lpage>974</lpage><pub-id pub-id-type="pmid">12244311</pub-id></citation></ref><ref id="pone.0003688-Nakagawa1"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakagawa</surname><given-names>K</given-names></name><name><surname>Iwabuchi</surname><given-names>K</given-names></name><name><surname>Ogasawara</surname><given-names>K</given-names></name><name><surname>Ato</surname><given-names>M</given-names></name><name><surname>Kajiwara</surname><given-names>M</given-names></name><etal/></person-group><year>1997</year><article-title>Generation of NK1.1&#x0002b; T cell antigen receptor alpha/beta&#x0002b; thymocytes associated with intact thymic structure.</article-title><source>Proc Natl Acad Sci U S A</source><volume>94</volume><fpage>2472</fpage><lpage>2477</lpage><pub-id pub-id-type="pmid">9122219</pub-id></citation></ref><ref id="pone.0003688-Lee1"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>PT</given-names></name><name><surname>Benlagha</surname><given-names>K</given-names></name><name><surname>Teyton</surname><given-names>L</given-names></name><name><surname>Bendelac</surname><given-names>A</given-names></name></person-group><year>2002</year><article-title>Distinct functional lineages of human V(alpha)24 natural killer T cells.</article-title><source>J Exp Med</source><volume>195</volume><fpage>637</fpage><lpage>641</lpage><pub-id pub-id-type="pmid">11877486</pub-id></citation></ref><ref id="pone.0003688-Watarai1"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Watarai</surname><given-names>H</given-names></name><name><surname>Nakagawa</surname><given-names>R</given-names></name><name><surname>Omori-Miyake</surname><given-names>M</given-names></name><name><surname>Dashtsoodol</surname><given-names>N</given-names></name><name><surname>Taniguchi</surname><given-names>M</given-names></name></person-group><year>2008</year><article-title>Methods for detection, isolation and culture of mouse and human invariant NKT cells.</article-title><source>Nat Protoc</source><volume>3</volume><fpage>70</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">18193023</pub-id></citation></ref></ref-list><fn-group><fn fn-type="conflict"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>This study was supported in part by a Grant-in-Aid for Scientific Research (S) from the Ministry of Education, Culture, Sports, Science and Technology, Japan to MT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></fn></fn-group></back></article> 